CLINICAL APPLICATION OF POLYACRYLAMIDE GEL DISC ELECTROPHORETIC ANALYSIS OF SERUM LIPOPROTEINS
Hypertriglyceridemia is seemed to be recognized as a key risk factor of coronary heart disease (CHD). To elucidate further risk factors of CHD, it is necessary to assess not only lipid metabolism but also combined risk factors known as syndrome X, and not all of CHD patients have been claimed hyperl...
Saved in:
Published in | Japanese Journal of National Medical Services Vol. 48; no. 5; pp. 354 - 359 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
Japanese Society of National Medical Services
1994
一般社団法人 国立医療学会 |
Subjects | |
Online Access | Get full text |
ISSN | 0021-1699 1884-8729 |
DOI | 10.11261/iryo1946.48.354 |
Cover
Abstract | Hypertriglyceridemia is seemed to be recognized as a key risk factor of coronary heart disease (CHD). To elucidate further risk factors of CHD, it is necessary to assess not only lipid metabolism but also combined risk factors known as syndrome X, and not all of CHD patients have been claimed hyperlipidemia. Therefore, serum cholesterol, triglyceride and HDL cholesterol alone are not sufficient to estimate the whole risk caused by lipoprotein abnormality. Lipoprotein disorders must be examined as metabolic disorders of VLDL and remnant cholesterol. In this study we used the Lipophor system and classified the electrophoretic patterns into four groups according to the variety of shape of LDL portion (S, A, N, and D classification). In normal subjects and patients with old myocardial infarction, diabetes mellitus, we examined the S, A, N, and D classification on their electrophoretic pattern and obtained the high frequency of abnormal electrophoretic patterns such as type N and type D. These abnormal electrophoretic patterns were markedly improved by administration of fibric acid derivative. In conclusion, the Lipophor system is easy to carry out and the classification of electrophoretic pattern is useful to assess the metabolic abnormality of lipoproteins. |
---|---|
AbstractList | Hypertriglyceridemia is seemed to be recognized as a key risk factor of coronary heart disease (CHD). To elucidate further risk factors of CHD, it is necessary to assess not only lipid metabolism but also combined risk factors known as syndrome X, and not all of CHD patients have been claimed hyperlipidemia. Therefore, serum cholesterol, triglyceride and HDL cholesterol alone are not sufficient to estimate the whole risk caused by lipoprotein abnormality. Lipoprotein disorders must be examined as metabolic disorders of VLDL and remnant cholesterol. In this study we used the Lipophor system and classified the electrophoretic patterns into four groups according to the variety of shape of LDL portion (S, A, N, and D classification).In normal subjects and patients with old myocardial infarction, diabetes mellitus, we examined the S, A, N, and D classification on their electrophoretic pattern and obtained the high frequency of abnormal electrophoretic patterns such as type N and type D. These abnormal electrophoretic patterns were markedly improved by administration of fibric acid derivative.In conclusion, the Lipophor system is easy to carry out and the classification of electrophoretic pattern is useful to assess the metabolic abnormality of lipoproteins.
近年, 高中性脂肪血症の冠動脈疾患への関与が明らかにされ, Syndrome Xという概念にみられるように脂質代謝異常のみならず耐糖能異常, 肥満, 高血圧症, 高インスリン血症を合併した症候群として冠動脈疾患の危険度を把握しようという傾向にある. かかる現状では従来のように, コレステロール, 中性脂肪, HDLコレステロールだけから冠動脈疾患の危険度を判断することは不十分であり, VLDLやレムナントを反映したリポ蛋白代謝の面から脂質代謝異常を検討することが必要である. 筆者らはリポ蛋白電気泳動を簡便に行えるLipophor systemを用い, 泳動像をLDL部分の形状により4型に分類(S, A, N, D分類)し動脈硬化性疾患発症の危険度の一つの指標としている. 本論文ではこの型分類を紹介し, 心筋梗塞や糖尿病では異常とみなされる型の出現頻度の高いことを示し, その異常が薬剤の投与により改善することを示した. Hypertriglyceridemia is seemed to be recognized as a key risk factor of coronary heart disease (CHD). To elucidate further risk factors of CHD, it is necessary to assess not only lipid metabolism but also combined risk factors known as syndrome X, and not all of CHD patients have been claimed hyperlipidemia. Therefore, serum cholesterol, triglyceride and HDL cholesterol alone are not sufficient to estimate the whole risk caused by lipoprotein abnormality. Lipoprotein disorders must be examined as metabolic disorders of VLDL and remnant cholesterol. In this study we used the Lipophor system and classified the electrophoretic patterns into four groups according to the variety of shape of LDL portion (S, A, N, and D classification). In normal subjects and patients with old myocardial infarction, diabetes mellitus, we examined the S, A, N, and D classification on their electrophoretic pattern and obtained the high frequency of abnormal electrophoretic patterns such as type N and type D. These abnormal electrophoretic patterns were markedly improved by administration of fibric acid derivative. In conclusion, the Lipophor system is easy to carry out and the classification of electrophoretic pattern is useful to assess the metabolic abnormality of lipoproteins. |
Author | OKADA, Koji MISHIMA, Yasuo KIKUCHI, Miyako KAMISAKA, Ken KIBATA, Masayoshi TAKAHASHI, Kiyoshi ANDO, Mitsuru |
Author_FL | 安藤 充 岡田 康司 菊地 都 三島 康男 木畑 正義 高橋 清 神坂 謙 |
Author_FL_xml | – sequence: 1 fullname: 三島 康男 – sequence: 2 fullname: 神坂 謙 – sequence: 3 fullname: 高橋 清 – sequence: 4 fullname: 木畑 正義 – sequence: 5 fullname: 安藤 充 – sequence: 6 fullname: 菊地 都 – sequence: 7 fullname: 岡田 康司 |
Author_xml | – sequence: 1 fullname: MISHIMA, Yasuo organization: Department of Internal Medicine, National Sanatorium Minami-okayama Hospital – sequence: 1 fullname: TAKAHASHI, Kiyoshi organization: Department of Internal Medicine, National Sanatorium Minami-okayama Hospital – sequence: 1 fullname: ANDO, Mitsuru organization: Minami-okayama National Sanatorium – sequence: 1 fullname: KIKUCHI, Miyako organization: Minami-okayama National Sanatorium – sequence: 1 fullname: KAMISAKA, Ken organization: Department of Internal Medicine, National Sanatorium Minami-okayama Hospital – sequence: 1 fullname: KIBATA, Masayoshi organization: Department of Internal Medicine, National Sanatorium Minami-okayama Hospital – sequence: 1 fullname: OKADA, Koji organization: Second Department of Internal Medicine, Okayama University Medical School |
BackLink | https://cir.nii.ac.jp/crid/1390001206315528704$$DView record in CiNii |
BookMark | eNo9kL1vwjAQxa2KSqWUvaOHrqH-jJ0xCgEsmThK0oGlkWOcNoiGKrDw3xdE2-W9k97v7qT3CEb9ofcAPGM0w5iE-LUbzgccsXDG5IxydgfGWEoWSEGiERgjRHCAwyh6ANPjsWsQIVywSPIxeE-0ylQSaxjnub4MlTIZNAuYG72Jk2Kj47Wap3CZajhXZQJTnSZVYfKVKdJKJTDOYr0pVXndKdPibQ21yk1emCpVWfkE7lu7P_rpr09AtUirZBVos7x-DXaYCRa0vG04D0PLMaMu9NZJTpqGEMdbKhGWvGUCk1Y0zG2l21LkW9Fa0biGIO7pBLzczvZdV7vuqphGCCFMUEgx50QKxC7Y_Ibtjif74evvofuyw7m2w6lze1__tVgzWfObXMr8j92nHWrf0x9fvmc_ |
ContentType | Journal Article |
Copyright | Japanese Society of National Medical Services |
Copyright_xml | – notice: Japanese Society of National Medical Services |
DBID | RYH |
DOI | 10.11261/iryo1946.48.354 |
DatabaseName | CiNii Complete |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Polyacrylamide gel disk電気泳動法によるリポ蛋白分画期測定の臨床的応用について |
DocumentTitle_FL | Polyacrylamide gel disk電気泳動法によるリポ蛋白分画期測定の臨床的応用について |
EISSN | 1884-8729 |
EndPage | 359 |
ExternalDocumentID | 130004314997 article_iryo1946_48_5_48_5_354_article_char_en |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS F5P JSF RJT RYH |
ID | FETCH-LOGICAL-j1474-f5fb5566a5143c6eac852bb22c5f380185f4712f7b4cd8cd30ef7fa7bcb205e3 |
ISSN | 0021-1699 |
IngestDate | Thu Jun 26 23:44:58 EDT 2025 Wed Sep 03 06:30:22 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j1474-f5fb5566a5143c6eac852bb22c5f380185f4712f7b4cd8cd30ef7fa7bcb205e3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/iryo1946/48/5/48_5_354/_article/-char/en |
PageCount | 6 |
ParticipantIDs | nii_cinii_1390001206315528704 jstage_primary_article_iryo1946_48_5_48_5_354_article_char_en |
PublicationCentury | 1900 |
PublicationDate | 1994 |
PublicationDateYYYYMMDD | 1994-01-01 |
PublicationDate_xml | – year: 1994 text: 1994 |
PublicationDecade | 1990 |
PublicationTitle | Japanese Journal of National Medical Services |
PublicationTitleAlternate | Japanese Journal of National Medical Services |
PublicationTitle_FL | 医療 Japanese Journal of National Medical Services |
PublicationYear | 1994 |
Publisher | Japanese Society of National Medical Services 一般社団法人 国立医療学会 |
Publisher_xml | – name: Japanese Society of National Medical Services – name: 一般社団法人 国立医療学会 |
References | 1) Kannel WB et al: Serum cholestrol, lipo-proteins, and the risk of coronary heart disease. The Framingham Study. Ann. Intern. Med., 74: 1, 1971 4) Grundy SM et al: Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment. Arch. Intern. Med., 152: 28, 1992 2) Goldbourt U et al: High density lipoprotein cholesterol and incidence of coronary heart disease-the Israeli Ischaemic Heart Disease Study. Am. J. Epidemiol., 109: 296, 1979 13) Kaplan NM: The deadly quartet. Arch. Intern. Med., 149: 1514, 1989 10) 都島基夫他: 動脈硬化症の臨床的研究 (第5報)-ヒトの粥状動脈硬化における血清脂質, 特に中間帯の意義について-, 動脈硬化, 14: 437, 1986 15) Vessby B et al: Effects of bezafibrate on the serum lipoprotein lipid and apolipo-protein composition, lipoprotein triglycer-ide removal capacity and the fatty acid composition of the plasma lipid esters. Atherosclerosis, 37: 257, 1980 9) 田代淳他: 家族性高コレステロール血症におけるMidbandの意義, 動脈硬化, 15: 1561, 1988 16) Heller F et al: Effects of clofibrate, be-zafibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects. Eur. J. Clin. Pharm., 25: 57, 1983 8) 馬淵宏他: 心筋梗塞患者における家族性高コレステロール血症および家族性複合型高脂血症の頻度, 動脈硬化, 16: 299, 1988 6) Iso H et al: Serum cholesterol levels and six-year mortality from stroke in 350, 977 men screened for the Multiple Risk Factor Intervention Trial. N. Engl. J. Med., 320: 904, 1989 14) Berndt J et al: Mode of action on the lip-id-lowering agents, clofibrate and BM 15, 075, on cholesterol biosynthesis in rat liver. Atherosclerosis, 30: 147, 1978 11) Roche D et al: Polyacrylamide gel electrophoresis in quantification of high-density lipoprotein cholesterol. Clin. Chem., 31: 1893, 1985 12) Reaven GM: Role of insulin resistance in human disease. Diabetes, 37: 1549, 1988 5) Manninen V et al: Joint effects of serum triglyceride and LDL cholesterol and HDL choresterol concentraions on coronary heart disease risk in the Helsinki Heart Study. Circulation, 85: 37, 1992 7) 垂井清一郎: 日本人における高脂血症とその合併症, 動脈硬化, 18: 1, 1990 3) Carlson LA et al: Risk factors for ischaemic heart disease in men and women. Re-sults of the 19-year follow-up of the Stockholm Prospective Study. Acta Med. Scand., 218: 207, 1985 |
References_xml | – reference: 1) Kannel WB et al: Serum cholestrol, lipo-proteins, and the risk of coronary heart disease. The Framingham Study. Ann. Intern. Med., 74: 1, 1971 – reference: 6) Iso H et al: Serum cholesterol levels and six-year mortality from stroke in 350, 977 men screened for the Multiple Risk Factor Intervention Trial. N. Engl. J. Med., 320: 904, 1989 – reference: 7) 垂井清一郎: 日本人における高脂血症とその合併症, 動脈硬化, 18: 1, 1990 – reference: 11) Roche D et al: Polyacrylamide gel electrophoresis in quantification of high-density lipoprotein cholesterol. Clin. Chem., 31: 1893, 1985 – reference: 16) Heller F et al: Effects of clofibrate, be-zafibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects. Eur. J. Clin. Pharm., 25: 57, 1983 – reference: 13) Kaplan NM: The deadly quartet. Arch. Intern. Med., 149: 1514, 1989 – reference: 5) Manninen V et al: Joint effects of serum triglyceride and LDL cholesterol and HDL choresterol concentraions on coronary heart disease risk in the Helsinki Heart Study. Circulation, 85: 37, 1992 – reference: 12) Reaven GM: Role of insulin resistance in human disease. Diabetes, 37: 1549, 1988 – reference: 15) Vessby B et al: Effects of bezafibrate on the serum lipoprotein lipid and apolipo-protein composition, lipoprotein triglycer-ide removal capacity and the fatty acid composition of the plasma lipid esters. Atherosclerosis, 37: 257, 1980 – reference: 4) Grundy SM et al: Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment. Arch. Intern. Med., 152: 28, 1992 – reference: 3) Carlson LA et al: Risk factors for ischaemic heart disease in men and women. Re-sults of the 19-year follow-up of the Stockholm Prospective Study. Acta Med. Scand., 218: 207, 1985 – reference: 2) Goldbourt U et al: High density lipoprotein cholesterol and incidence of coronary heart disease-the Israeli Ischaemic Heart Disease Study. Am. J. Epidemiol., 109: 296, 1979 – reference: 8) 馬淵宏他: 心筋梗塞患者における家族性高コレステロール血症および家族性複合型高脂血症の頻度, 動脈硬化, 16: 299, 1988 – reference: 14) Berndt J et al: Mode of action on the lip-id-lowering agents, clofibrate and BM 15, 075, on cholesterol biosynthesis in rat liver. Atherosclerosis, 30: 147, 1978 – reference: 9) 田代淳他: 家族性高コレステロール血症におけるMidbandの意義, 動脈硬化, 15: 1561, 1988 – reference: 10) 都島基夫他: 動脈硬化症の臨床的研究 (第5報)-ヒトの粥状動脈硬化における血清脂質, 特に中間帯の意義について-, 動脈硬化, 14: 437, 1986 |
SSID | ssib022574985 ssib001535802 ssib023002185 ssib058493029 ssj0000744927 ssib000871959 ssib039897558 ssib020483960 ssib023167316 |
Score | 1.3958371 |
Snippet | Hypertriglyceridemia is seemed to be recognized as a key risk factor of coronary heart disease (CHD). To elucidate further risk factors of CHD, it is necessary... |
SourceID | nii jstage |
SourceType | Publisher |
StartPage | 354 |
SubjectTerms | coronary risk factor, lipoprotein metabolism hypertriglyceridemia PAG electro-phoretic classification PAG電気泳動型分類 冠疾患危険因子リポ蛋白代謝 高中性脂肪血症 |
Title | CLINICAL APPLICATION OF POLYACRYLAMIDE GEL DISC ELECTROPHORETIC ANALYSIS OF SERUM LIPOPROTEINS |
URI | https://www.jstage.jst.go.jp/article/iryo1946/48/5/48_5_354/_article/-char/en https://cir.nii.ac.jp/crid/1390001206315528704 |
Volume | 48 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Japanese Journal of National Medical Services, 1994/05/20, Vol.48(5), pp.354-359 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Pj5NAFJ5014sXo1Hjqms4eGuoBQZm5uCBtKytpQVbmmwvEihMpCat6Y9D_Uf9d3zDMJSuJrp6mRToEJg3773vPWa-h9BbACFJljuOTrqU6ZjQVKc0J7qZkoRyjPOMi93I44kzmOOPt_Ztq_WjsWrpsE87y--_3VfyL1KFcyBXsUv2HpKtbwon4DfIF1qQMLR_JeOeP5xIcsYwVFuCxTKeMPAXbm-68N3xsO-1P3h-uz-cgdHzvV40DcJBMPUiGH534vqL2bAsXz7zpvMx2LIwCKdB5KmgXuFW8KmiVmW7AWAnKo-oPvYou1MLUSTDxm5p5ZPdYVNnCdyRO3DhWmlliuNm96WoJ96kH8jl_PvdYXuo_cFwNO_JDuPimHzdnLIVgnb45EPUc6rVqH98TrXbQBSylkWUOrk00pRisOJVpqSy4pg2ZqvdMMmWJKmuvLsl-cd_dRwQSYK4i-1xYzDsdDDt1B3P6LgrYcfqnzGmsS0b6BCry2LPHEzRC_TAJMQQa01Hn5q4l5yR-oDbsemJh02QKVvsFLeCzSWYnUiGIGwU0KxxbDiiApk6thhlpMHjBiCTWerzawlRCMZMlTOW46s-4cM4vLszCgDOVhCqCA6Ki3VRNPBX9Bg9quad5so3f4Jaq-Qp-qw0QGtogBbcaOcaoIEGaEIDtDsaoCkNEH1KDdCaGvAMRTde1BvoVcUQfWVggnVu89SGACURYcDSAVBBbTNNTXNpcwuwGLU5gDGTkxQLTozM6uac8ISky9Ts2rn1HF2uN-v8BdJyg2eMJZaRORlgbJ4YWUKZ2eVZwnJCyBV6L8ck_iZZYeL7TYwrdA1DGS8L0UIUVmaEIVwQjIjgQvHL_7z_K_RQsn6LZOFrdLnfHvJrgM_79E05FX8CNQSsdA |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CLINICAL+APPLICATION+OF+POLYACRYLAMIDE+GEL+DISC+ELECTROPHORETIC+ANALYSIS+OF+SERUM+LIPOPROTEINS&rft.jtitle=Japanese+Journal+of+National+Medical+Services&rft.au=MISHIMA%2C+Yasuo&rft.au=TAKAHASHI%2C+Kiyoshi&rft.au=ANDO%2C+Mitsuru&rft.au=KIKUCHI%2C+Miyako&rft.date=1994&rft.pub=Japanese+Society+of+National+Medical+Services&rft.issn=0021-1699&rft.eissn=1884-8729&rft.volume=48&rft.issue=5&rft.spage=354&rft.epage=359&rft_id=info:doi/10.11261%2Firyo1946.48.354&rft.externalDocID=article_iryo1946_48_5_48_5_354_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-1699&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-1699&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-1699&client=summon |